Solriamfetol: what it treats, how to take it, side effects

Different jobs: solriamfetol manages the daytime symptom - sleepiness; the CPAP treats the cause - the breathing interruptions shredding your sleep architecture all night. Stopping the device because the days feel better is the classic trap: the nights get worse silently, and the daytime drug fights a losing battle. The pair is the treatment; neither replaces the other.

The wakefulness is the point and the problem: the same brain substances that clear the daytime fog will occupy your night if the drug is still on board at bedtime. Once in the morning, same time - and the afternoon dose that tempts on hard days is exactly the one that costs the night. A missed morning dose is skipped, not compensated at 2 PM.

It is a controlled substance - the potential is real: the dose is the dose, and chasing extra wakefulness with extra tablets is the path the schedule exists to block. Used at the prescribed morning dose for a real diagnosis, dependence stays a theoretical risk; the diary and the prescriber visits keep it that way.

It can raise blood pressure and heart rate - the checks come with the drug: at the start, after dose changes, and periodically after. High blood pressure and heart disease shape the dose before the first tablet. The report-fast set: chest pain, fast or pounding heartbeat, shortness of breath.

Report it, never self-escalate: breakthrough sleepiness has causes - device compliance slipping, weight change, the dose needing review, another sleep disorder joining - and each has a different fix. The afternoon nap question and the caffeine budget both belong to the sleep specialist's plan, not improvisation.

If the morning is gone, skip it - a late dose costs the night, and the night is what the whole regimen protects. Never double up. One missed morning is a groggy day, not a crisis; the 7 AM anchor keeps them rare.